India Today Business Desk · DistrictNews · 2026-08-20
Moderna shares soar 177% after cancer vaccine breakthrough
Moderna and Merck said their experimental mRNA cancer treatment met goals in a late-stage melanoma trial. The result reduced the risk of recurrence or spread versus Keytruda alone and lifted Moderna shares sharply. Moderna shares soar 177% after cancer vaccine breakthrough
Read original on India Today Business Desk Get the app
Licensed summary · LicensedSummary
Related briefs
- Dharwad bans PoP Ganesh idols, announces ₹1 lakh fine for excessive DJ sound
- Delhi government asks schools to conduct baseline tests for classes 2 to 8 students
- Punjab turns to bamboo as new diversification option; Centre approves Rs 2.49cr
- ‘No fraud’: MP High Court quashes Rs 1 lakh recovery from widow over ‘excess salary’
- Mumbai Model Who Stopped Police Van Amid Gen Z Protests Now Seeks FIR Withdrawal, Action Over Threats